"This represents an important milestone in ensuring that Rapiblyk™ availability is secured nationwide, supporting clinicians ...
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
AccurKardia, an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool ...
Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.
Stockhead on MSN
Scott Power: ASX healthcare stocks lift as sentiment improves
Morgans Scott Power positive of renewed momentum in the healthcare sector, which has risen 0.7% in the week ending January 16 ...
Cardiac Electrophysiology Institute Expands Catheter Ablation Access For Los Angeles Heart Rhythm Patients. <a href = target= ...
The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...
After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...
The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced. The rapid-acting L-type calcium ...
Physical therapy, which starts with semi-reclined exercises, can improve your POTS symptoms. You can wear compression garments and increase your fluid and sodium intake to manage POTS. There are no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback